NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $611,362 | -18.4% | 1,026,464 | -21.2% | 0.00% | – |
| Q2 2023 | $749,122 | +1.3% | 1,302,369 | +23.8% | 0.00% | – |
| Q1 2023 | $739,464 | -69.8% | 1,052,019 | -2.9% | 0.00% | -100.0% |
| Q4 2022 | $2,449,821 | -30.6% | 1,083,992 | -1.7% | 0.00% | 0.0% |
| Q3 2022 | $3,528,000 | +32.3% | 1,102,617 | +57.1% | 0.00% | 0.0% |
| Q2 2022 | $2,667,000 | +0.7% | 701,883 | +42.8% | 0.00% | 0.0% |
| Q1 2022 | $2,649,000 | -57.5% | 491,447 | +6.7% | 0.00% | 0.0% |
| Q4 2021 | $6,227,000 | -31.2% | 460,797 | -8.6% | 0.00% | -50.0% |
| Q3 2021 | $9,057,000 | -22.0% | 504,330 | -25.4% | 0.00% | 0.0% |
| Q2 2021 | $11,607,000 | +26.2% | 676,377 | +47.0% | 0.00% | 0.0% |
| Q1 2021 | $9,200,000 | -47.4% | 459,974 | -55.3% | 0.00% | -60.0% |
| Q4 2020 | $17,497,000 | +12.7% | 1,029,234 | +10.0% | 0.01% | +25.0% |
| Q3 2020 | $15,525,000 | -59.8% | 935,848 | -43.8% | 0.00% | -66.7% |
| Q2 2020 | $38,592,000 | +19.2% | 1,666,290 | -8.1% | 0.01% | +9.1% |
| Q1 2020 | $32,379,000 | -23.2% | 1,813,950 | -7.2% | 0.01% | 0.0% |
| Q4 2019 | $42,176,000 | +79.2% | 1,953,933 | +51.3% | 0.01% | +57.1% |
| Q3 2019 | $23,531,000 | -23.8% | 1,291,802 | +48.8% | 0.01% | -22.2% |
| Q2 2019 | $30,886,000 | +16.1% | 868,084 | +9.6% | 0.01% | +12.5% |
| Q1 2019 | $26,613,000 | -7.6% | 792,043 | -9.6% | 0.01% | -11.1% |
| Q4 2018 | $28,810,000 | -60.4% | 876,493 | -26.6% | 0.01% | -50.0% |
| Q3 2018 | $72,750,000 | +3.1% | 1,193,394 | -17.4% | 0.02% | -5.3% |
| Q2 2018 | $70,544,000 | -55.8% | 1,444,685 | -3.9% | 0.02% | -53.7% |
| Q1 2018 | $159,674,000 | +276.1% | 1,502,673 | +111.4% | 0.04% | +272.7% |
| Q4 2017 | $42,457,000 | +71.9% | 710,933 | -30.9% | 0.01% | +83.3% |
| Q3 2017 | $24,696,000 | +43.7% | 1,029,025 | +17.0% | 0.01% | +50.0% |
| Q2 2017 | $17,191,000 | +13.8% | 879,338 | +36.7% | 0.00% | 0.0% |
| Q1 2017 | $15,101,000 | +156.4% | 643,437 | +34.0% | 0.00% | +100.0% |
| Q4 2016 | $5,890,000 | -59.2% | 480,039 | -42.9% | 0.00% | -50.0% |
| Q3 2016 | $14,437,000 | +157.1% | 840,331 | +112.9% | 0.00% | +100.0% |
| Q2 2016 | $5,616,000 | +11.3% | 394,624 | +7.5% | 0.00% | 0.0% |
| Q1 2016 | $5,045,000 | -36.2% | 366,937 | -21.8% | 0.00% | 0.0% |
| Q4 2015 | $7,908,000 | +86.2% | 469,267 | +21.1% | 0.00% | +100.0% |
| Q3 2015 | $4,246,000 | -35.8% | 387,429 | -26.8% | 0.00% | -50.0% |
| Q2 2015 | $6,618,000 | -22.6% | 529,040 | -31.9% | 0.00% | 0.0% |
| Q1 2015 | $8,547,000 | +69.7% | 776,986 | +139.1% | 0.00% | 0.0% |
| Q4 2014 | $5,037,000 | -35.0% | 324,981 | -49.4% | 0.00% | 0.0% |
| Q3 2014 | $7,745,000 | +54.1% | 641,686 | +63.7% | 0.00% | +100.0% |
| Q2 2014 | $5,025,000 | +34.0% | 391,985 | +26.7% | 0.00% | 0.0% |
| Q1 2014 | $3,750,000 | -9.7% | 309,371 | -15.5% | 0.00% | 0.0% |
| Q4 2013 | $4,155,000 | -5.7% | 366,015 | -13.3% | 0.00% | 0.0% |
| Q3 2013 | $4,408,000 | +32.7% | 422,017 | +46.7% | 0.00% | 0.0% |
| Q2 2013 | $3,323,000 | +251.3% | 287,668 | +125.5% | 0.00% | – |
| Q4 2012 | $946,000 | -28.3% | 127,597 | +3.1% | 0.00% | -100.0% |
| Q3 2012 | $1,320,000 | +10.4% | 123,709 | -16.6% | 0.00% | 0.0% |
| Q2 2012 | $1,196,000 | +38.9% | 148,315 | +36.4% | 0.00% | – |
| Q1 2012 | $861,000 | – | 108,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |